TBD | The Rise of Off-Brand Ozempic

Aug 18, 2024

Kate Knibbs, a senior writer at Wired, dives into the booming off-brand weight loss medication market, particularly alternatives to Ozempic. She discusses the troubling accessibility of these drugs through online pharmacies and telehealth services. The conversation touches on the risks and regulatory challenges associated with compounded medications. Knibbs calls attention to the ethical dilemmas in patient transparency and the importance of consulting healthcare professionals before making decisions about weight loss treatments.

Ask episode

Chapters

Transcript

Episode notes

Intro

00:00 • 2min

The Risks of Off-Brand Weight Loss Medications

02:17 • 5min

Compounding Pharmacies: Risks and Regulations

06:49 • 4min

The Intersection of Compounded Drugs and Financial Innovations

10:52 • 2min

Navigating Telehealth and Prescription Medications

12:30 • 8min

Navigating the World of Compounded Medications Safely

20:04 • 3min